Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
| Website: | www.globusmedical.com |
| Main Phone: | +1 610 930-1800 |
| Address: | 2560 General Armistead Avenue |
| State: | PA |
| City / Town: | Audubon |
| Country: | USA |
| Postal Code: | 19403 |
| Exchange: | NYE |
| CEO: | David M. Demski |
| Employees: | 1500 |
| NAICS: | Surgical and Medical Instrument Manufacturing (339112) |
| Last Price 52.02 | Change $ -0.03 | Change % -0.06 | Tick N/A |
| Bid 20.33 | Bid Size 100.00 | Ask N/A | Ask Size 0.00 |
| Open 52.01 | High 52.30 | Low 51.78 | Prev Close 52.05 |
| Last Trade | Volume 252,207 | 52 Wk Hi 57.55 | 52 Wk Low 27.79 |
| Market Cap 5.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 97,466,724.00 | EPS (TTM) 1.19 | PE Ratio 43.70 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 70 | 110 |
| Number of Buys | 22 | 42 |
| Number of Sells | 48 | 68 |
| Net Activity | -1171775 | -812734 |
| Last 10 Buys | Shares |
|---|---|
| N/A | 0 |
| Last 10 Sell | Shares |
|---|---|
| Steven M. Payne | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 65 | 60 | 60 | 65 |
| Low Target Price Estimate | 37 | 37 | 37 | 37 |
| Mean Target Price Estimate | 55.78 | 54.5 | 54.5 | 55.78 |
| Standard Deviation | 7.97 | 7.56 | 7.56 | 7.97 |
| Date of Most Recent Estimate | 06/01/18 | 05/04/18 | 05/04/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| SD | Specialized Disclosure Report | 3 | 2018-05-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 43 | 2018-05-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2018-05-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-30 |
| DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2018-04-26 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 51 | 2018-04-26 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-20 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 7 | 7 |
| Moderate Buy | 1 | 1 | 1 | 0 |
| Hold | 4 | 5 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 |
| Mean Rec. | 1.9 | 2.1 | 1.75 | 2 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
